Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
62%
Primary Antibody Deficiency
50%
Replacement Product
40%
Immunoglobulin Replacement
40%
Antibody Deficiency
35%
Neutralizing Activity
35%
MRNA Vaccine
31%
Omicron Variant
29%
Antibody Response
28%
IgG1
25%
Memory B-cell Response
25%
Booster Vaccination
25%
Adult Patients
25%
Immunodeficiency
25%
Gene Sequencing
25%
SARS-CoV-2 Infection
25%
Allergic Reaction
25%
SARS-CoV-2 mRNA Vaccination
25%
Reaction Mechanism
25%
Complement Activation
18%
Immunoglobulin
16%
Anti-spike
15%
Basophils
12%
Non-allergic
12%
Glycol
12%
B Cell Response
10%
Primary Vaccination
10%
Receptor-binding Domain
10%
Titer
10%
Antireceptor
10%
Vaccination
9%
Protective Behavior
9%
Healthy Donors
9%
Immunoglobulin Prophylaxis
8%
Immune Deficiency
8%
XBB.1.5
8%
SARS-CoV-2 Vaccine
7%
Memory B Cells
7%
Healthy Individuals
7%
T Cell Response
7%
Interleukin-13 (IL-13)
6%
COVID-19 mRNA Vaccine
6%
Interleukin-1β
6%
Complement C5a Receptor
6%
Single-cell multi-omics
6%
Cytokine Response
6%
Novel Nanoparticles
6%
Chromatin Accessibility
6%
COVID-19 Vaccine
6%
Number of Individuals
6%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Humoral Immune Deficiency
50%
Intravenous Immunoglobulin
41%
Infection
32%
Omicron Coronavirus Variant
31%
COVID-19
29%
Antibody Response
28%
Immunodeficiency
25%
Gene Sequence
25%
Immunoglobulin G1
25%
Memory B Cell
25%
Hypersensitive Response
25%
Complement Activation
18%
Spike
15%
Receptor Binding
12%
Basophil
12%
Basophil Activation
12%
B Cell
10%
Titer
8%
Immune Response
7%
T Cell
7%
Antibody Titer
6%
Cytokine Response
6%
Receptor Blocking
6%
Toll-Like Receptor
6%
Complement Component C5a Receptor
6%
Immunoglobulin E
6%
Complement Component 5a
6%
C3a (Complement)
6%
Mononuclear Phagocyte
6%
Interleukin 13
6%
Immunoglobulin M
6%
Immunodeficiency
5%